PUBMED FOR HANDHELDS

Journal Abstract Search


839 related items for PubMed ID: 17666187

  • 1. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.
    Buckley TM, Mullen BC, Schatzberg AF.
    Psychoneuroendocrinology; 2007; 32(8-10):859-64. PubMed ID: 17666187
    [Abstract] [Full Text] [Related]

  • 2. Overnight suppression of HPA axis after mineraolocorticoid receptor stimulation: A sleep endocrine study.
    Demiralay C, Agorastos A, Jahn H, Kellner M, Yassouridis A, Wiedemann K.
    Psychiatry Res; 2015 May 30; 227(1):65-70. PubMed ID: 25799272
    [Abstract] [Full Text] [Related]

  • 3. The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.
    Lembke A, Gomez R, Tenakoon L, Keller J, Cohen G, Williams GH, Kraemer FB, Schatzberg AF.
    Psychoneuroendocrinology; 2013 Jan 30; 38(1):115-21. PubMed ID: 22727477
    [Abstract] [Full Text] [Related]

  • 4. Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone.
    Otte C, Muhtz C, Daneshkhah S, Yassouridis A, Kiefer F, Wiedemann K, Kellner M.
    Biol Psychiatry; 2006 Oct 01; 60(7):784-7. PubMed ID: 16566900
    [Abstract] [Full Text] [Related]

  • 5. The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone.
    Otte C, Jahn H, Yassouridis A, Arlt J, Stober N, Maass P, Wiedemann K, Kellner M.
    Life Sci; 2003 Aug 22; 73(14):1835-45. PubMed ID: 12888122
    [Abstract] [Full Text] [Related]

  • 6. Mineralocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in aged humans.
    Otte C, Yassouridis A, Jahn H, Maass P, Stober N, Wiedemann K, Kellner M.
    J Gerontol A Biol Sci Med Sci; 2003 Oct 22; 58(10):B900-5. PubMed ID: 14570856
    [Abstract] [Full Text] [Related]

  • 7. The acute effect of a mineralocorticoid receptor agonist on corticotrope secretion in Addison's disease.
    Berardelli R, Karamouzis I, D'Angelo V, Fussotto B, Minetto MA, Ghigo E, Giordano R, Arvat E.
    J Endocrinol Invest; 2016 May 22; 39(5):537-42. PubMed ID: 26450146
    [Abstract] [Full Text] [Related]

  • 8. The acute effect of fludrocortisone on basal and hCRH-stimulated hypothalamic--pituitary--adrenal (HPA) axis in humans.
    Karamouzis I, Berardelli R, Marinazzo E, D'Angelo V, Zinnà D, Minetto MA, Zichi C, Fussotto B, Giordano R, Ghigo E, Arvat E.
    Pituitary; 2013 Sep 22; 16(3):378-85. PubMed ID: 23011321
    [Abstract] [Full Text] [Related]

  • 9. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans.
    Berardelli R, Karamouzis I, Marinazzo E, Prats E, Picu A, Giordano R, Ghigo E, Arvat E.
    Eur J Endocrinol; 2010 Jun 22; 162(6):1067-74. PubMed ID: 20219855
    [Abstract] [Full Text] [Related]

  • 10. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R.
    J Neuroendocrinol; 1996 Aug 22; 8(8):579-85. PubMed ID: 8866244
    [Abstract] [Full Text] [Related]

  • 11. Experimentally challenged reactivity of the hypothalamic pituitary adrenal axis in patients with recently diagnosed rheumatoid arthritis.
    Dekkers JC, Geenen R, Godaert GL, Glaudemans KA, Lafeber FP, van Doornen LJ, Bijlsma JW.
    J Rheumatol; 2001 Jul 22; 28(7):1496-504. PubMed ID: 11469453
    [Abstract] [Full Text] [Related]

  • 12. Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade.
    Giordano R, Bo M, Pellegrino M, Vezzari M, Baldi M, Picu A, Balbo M, Bonelli L, Migliaretti G, Ghigo E, Arvat E.
    J Clin Endocrinol Metab; 2005 Oct 22; 90(10):5656-62. PubMed ID: 16014406
    [Abstract] [Full Text] [Related]

  • 13. The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback.
    Raubenheimer PJ, Young EA, Andrew R, Seckl JR.
    Clin Endocrinol (Oxf); 2006 Jul 22; 65(1):22-6. PubMed ID: 16817814
    [Abstract] [Full Text] [Related]

  • 14. Influence of exogenous atrial natriuretic peptide on the nocturnal hypothalamic-pituitary-adrenal axis and sleep in healthy men.
    Demiralay C, Jahn H, Kellner M, Yassouridis A, Wiedemann K.
    Psychoneuroendocrinology; 2010 Nov 22; 35(10):1438-45. PubMed ID: 20554120
    [Abstract] [Full Text] [Related]

  • 15. Chronic subcutaneous leptin infusion diminishes the responsiveness of the hypothalamic-pituitary-adrenal (HPA) axis in female rhesus monkeys.
    Wilson ME, Fisher J, Brown J.
    Physiol Behav; 2005 Mar 16; 84(3):449-58. PubMed ID: 15763583
    [Abstract] [Full Text] [Related]

  • 16. The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans.
    Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H.
    J Clin Endocrinol Metab; 1998 Sep 16; 83(9):3339-45. PubMed ID: 9745451
    [Abstract] [Full Text] [Related]

  • 17. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
    Chittiprol S, Kumar AM, Satishchandra P, Taranath Shetty K, Bhimasena Rao RS, Subbakrishna DK, Philip M, Satish KS, Ravi Kumar H, Kumar M.
    Psychoneuroendocrinology; 2008 Jan 16; 33(1):30-40. PubMed ID: 17993249
    [Abstract] [Full Text] [Related]

  • 18. In healthy young and elderly adults, hypothalamic-pituitary-adrenocortical axis reactivity (HPA AR) varies with increasing pharmacological challenge and with age, but not with gender.
    Hatzinger M, Brand S, Herzig N, Holsboer-Trachsler E.
    J Psychiatr Res; 2011 Oct 16; 45(10):1373-80. PubMed ID: 21641616
    [Abstract] [Full Text] [Related]

  • 19. Effect of chronic alcohol consumption on the activity of the hypothalamic-pituitary-adrenal axis and pituitary beta-endorphin as a function of alcohol intake, age, and gender.
    Gianoulakis C, Dai X, Brown T.
    Alcohol Clin Exp Res; 2003 Mar 16; 27(3):410-23. PubMed ID: 12658106
    [Abstract] [Full Text] [Related]

  • 20. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL, Liberzon I, Young EA, Khan S.
    Arch Gen Psychiatry; 2005 Jun 16; 62(6):668-75. PubMed ID: 15939844
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 42.